http://purl.org/np/RAAAG1pNeyn38vSM1maMvlk2gtDES8WZW8wjVLVNEcjdk#Head http://purl.org/np/RAAAG1pNeyn38vSM1maMvlk2gtDES8WZW8wjVLVNEcjdk http://www.nanopub.org/nschema#hasAssertion http://purl.org/np/RAAAG1pNeyn38vSM1maMvlk2gtDES8WZW8wjVLVNEcjdk#assertion http://purl.org/np/RAAAG1pNeyn38vSM1maMvlk2gtDES8WZW8wjVLVNEcjdk http://www.nanopub.org/nschema#hasProvenance http://purl.org/np/RAAAG1pNeyn38vSM1maMvlk2gtDES8WZW8wjVLVNEcjdk#provenance http://purl.org/np/RAAAG1pNeyn38vSM1maMvlk2gtDES8WZW8wjVLVNEcjdk http://www.nanopub.org/nschema#hasPublicationInfo http://purl.org/np/RAAAG1pNeyn38vSM1maMvlk2gtDES8WZW8wjVLVNEcjdk#pubinfo http://purl.org/np/RAAAG1pNeyn38vSM1maMvlk2gtDES8WZW8wjVLVNEcjdk http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://purl.org/np/RAAAG1pNeyn38vSM1maMvlk2gtDES8WZW8wjVLVNEcjdk#assertion https://uts.nlm.nih.gov/uts/umls/concept/C0012634 http://wordnet-rdf.princeton.edu/lemma/modifying https://uts.nlm.nih.gov/uts/umls/concept/C0003191 http://purl.org/np/RAAAG1pNeyn38vSM1maMvlk2gtDES8WZW8wjVLVNEcjdk#provenance http://purl.org/np/RAAAG1pNeyn38vSM1maMvlk2gtDES8WZW8wjVLVNEcjdk#_assertion http://www.w3.org/ns/prov#wasGeneratedBy S&T TWOC Project - version 4 http://purl.org/np/RAAAG1pNeyn38vSM1maMvlk2gtDES8WZW8wjVLVNEcjdk#_assertion http://www.w3.org/ns/prov#wasGeneratedBy S&T TWOC version 3 http://purl.org/np/RAAAG1pNeyn38vSM1maMvlk2gtDES8WZW8wjVLVNEcjdk#_version http://www.w3.org/ns/prov#value 2 http://purl.org/np/RAAAG1pNeyn38vSM1maMvlk2gtDES8WZW8wjVLVNEcjdk#assertion http://www.w3.org/ns/prov#generatedAtTime 2023-07-20T09:47:09.194030 http://purl.org/np/RAAAG1pNeyn38vSM1maMvlk2gtDES8WZW8wjVLVNEcjdk#assertion http://www.w3.org/ns/prov#wasAttributedTo https://orcid.org/0000-0003-4692-1377 http://purl.org/np/RAAAG1pNeyn38vSM1maMvlk2gtDES8WZW8wjVLVNEcjdk#assertion http://www.w3.org/ns/prov#wasDerivedFrom https://doi.org/10.1007/s10067-021-05743-2 http://www.w3.org/1999/02/22-rdf-syntax-ns#OBJECT http://www.w3.org/2000/01/rdf-schema#label anti-rheumatic drugs ( DMARDs ) http://www.w3.org/1999/02/22-rdf-syntax-ns#OBJECT-POSITION http://www.w3.org/2000/01/rdf-schema#label (53, 60) http://www.w3.org/1999/02/22-rdf-syntax-ns#PREDICATE http://www.w3.org/2000/01/rdf-schema#label modifying http://www.w3.org/1999/02/22-rdf-syntax-ns#PREDICATE-POSITION http://www.w3.org/2000/01/rdf-schema#label 61, 70 http://www.w3.org/1999/02/22-rdf-syntax-ns#SUBJECT http://www.w3.org/2000/01/rdf-schema#label disease http://www.w3.org/1999/02/22-rdf-syntax-ns#SUBJECT-POSITION http://www.w3.org/2000/01/rdf-schema#label (53, 60) http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement http://www.w3.org/2000/01/rdf-schema#label The pharmacotherapy of Takayasu arteritis (TAK) with disease-modifying anti-rheumatic drugs (DMARDs) is an evolving area. http://www.w3.org/2000/01/rdf-schema#ABSTRACT-UID http://localhost:8555/solr/triples/select?fl=TRIPLE_UID,%20CORD_UID,%20SUBJECT,%20PREDICATE,%20WORDNET_SEMREL,%20%20OBJECT,%20PRED_POSITION,%20SUBJECT_CUIS,%20OBJECT_CUIS,%20UMLS_SEMREL,%20PRED_POSITION,%20PREDICATE-LEMMA&q=CORD_UID:fcy3fn4c&rows=50 fcy3fn4c http://www.w3.org/2000/01/rdf-schema#TRIPLE-UID http://localhost:8555/solr/triplesselect?q=TRIPLE_UID:fcy3fn4c-TRIPLE-ABSTRACT-1 fcy3fn4c-TRIPLE-ABSTRACT-1 https://uts.nlm.nih.gov/uts/umls/concept/C0003191 http://www.w3.org/2000/01/rdf-schema#label anti-rheumatic drugs https://uts.nlm.nih.gov/uts/umls/concept/C0012634 http://www.w3.org/2000/01/rdf-schema#label disease http://purl.org/np/RAAAG1pNeyn38vSM1maMvlk2gtDES8WZW8wjVLVNEcjdk#pubinfo http://purl.org/np/RAAAG1pNeyn38vSM1maMvlk2gtDES8WZW8wjVLVNEcjdk#sig http://purl.org/nanopub/x/hasAlgorithm RSA http://purl.org/np/RAAAG1pNeyn38vSM1maMvlk2gtDES8WZW8wjVLVNEcjdk#sig http://purl.org/nanopub/x/hasPublicKey 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 http://purl.org/np/RAAAG1pNeyn38vSM1maMvlk2gtDES8WZW8wjVLVNEcjdk#sig http://purl.org/nanopub/x/hasSignature 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 http://purl.org/np/RAAAG1pNeyn38vSM1maMvlk2gtDES8WZW8wjVLVNEcjdk#sig http://purl.org/nanopub/x/hasSignatureTarget http://purl.org/np/RAAAG1pNeyn38vSM1maMvlk2gtDES8WZW8wjVLVNEcjdk http://purl.org/np/RAAAG1pNeyn38vSM1maMvlk2gtDES8WZW8wjVLVNEcjdk http://www.w3.org/ns/prov#wasAttributedTo https://orcid.org/0000-0003-4692-1377